The plan consists of 4 phases primarily based on precedence teams. The primary three phases will represent the vaccination of 49,650,255 individuals and may begin in February, in keeping with well being authorities.
The precedence teams will embody well being and academic employees, the indigenous inhabitants, aged individuals over 75 years outdated, these with pre-existing well being circumstances, safety forces and transport officers and inmates, amongst others.
“As well as, a memoranda of understanding was achieved with the pharmaceutical firm Pfizer to accumulate 70 million doses –8.5 million doses by June 2021, with 2 million doses anticipated for the primary quarter– and with the pharmaceutical firm Janssen, for the acquisition of 38 million doses, of those, 3 million doses for the second quarter of 2021,” says the assertion.
Moreover, on the finish of September, the state of Sao Paulo signed an settlement with Chinese language SinoVac to obtain thousands and thousands of doses of the potential vaccine. Sinovac and Brazilian main biomedical analysis middle, the Butantan Institute, performed Part III trials of the vaccine in Brazil.
“All vaccines produced in Brazil, by Butantan, Fiocruz or by any business, could have the precedence of SUS (Brazil’s nationwide well being system),” Pazuello mentioned.
In Brazil, 4 vaccines are in Part III testing: AstraZeneca, Janssen, Sinovac and Pfizer. None have requested emergency registration with ANVISA up to now, in keeping with a Wednesday assertion from the nation’s well being ministry.